Squarepoint Ops LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$27,000
-82.2%
13,182
-66.4%
0.00%
Q3 2021$152,000
-15.6%
39,191
-30.2%
0.00%
-100.0%
Q2 2021$180,000
+328.6%
56,128
+286.1%
0.00%
Q4 2019$42,000
-17.6%
14,537
+4.6%
0.00%
Q3 2019$51,000
+21.4%
13,901
+37.5%
0.00%
Q2 2019$42,000
-76.3%
10,113
-65.7%
0.00%
-100.0%
Q3 2018$177,000
+68.6%
29,525
+78.1%
0.00%
+100.0%
Q2 2018$105,00016,5780.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders